Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 32 | $2,704,181 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
07 Jul 2022 16:06 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 05 Jul 2022 | Sale | 1,754 | 150 | 263,100 | D |
05 Aug 2022 16:15 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 05 Aug 2022 | Sale | 104 | 225.15 | 23,416 | D |
05 Aug 2022 16:15 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 05 Aug 2022 | Sale | 5 | 224 | 1,120 | D |
05 Aug 2022 16:15 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 05 Aug 2022 | Sale | 105 | 220.95 | 23,200 | D |
05 Aug 2022 16:15 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 05 Aug 2022 | Sale | 99 | 219.53 | 21,733 | D |
05 Aug 2022 16:15 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 05 Aug 2022 | Sale | 541 | 218.71 | 118,322 | D |
05 Aug 2022 16:15 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 05 Aug 2022 | Sale | 440 | 217.61 | 95,748 | D |
05 Aug 2022 16:15 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 05 Aug 2022 | Sale | 398 | 216.21 | 86,052 | D |
05 Aug 2022 16:15 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 05 Aug 2022 | Sale | 149 | 215.03 | 32,039 | D |
05 Aug 2022 16:15 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 03 Aug 2022 | Sale | 1,754 | 210 | 368,340 | D |
03 Feb 2023 17:45 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 03 Feb 2023 | Sale | 953 | 233.31 | 222,344 | D |
03 Feb 2023 17:45 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 03 Feb 2023 | Sale | 1,293 | 232.53 | 300,661 | D |
03 Feb 2023 17:45 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 03 Feb 2023 | Sale | 865 | 231.35 | 200,118 | D |
03 Feb 2023 17:45 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 03 Feb 2023 | Sale | 185 | 230.2 | 42,587 | D |
03 Feb 2023 17:45 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 03 Feb 2023 | Sale | 128 | 227.68 | 29,143 | D |
03 Feb 2023 17:45 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 02 Feb 2023 | Sale | 4 | 227.38 | 910 | D |
03 Feb 2023 17:45 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 02 Feb 2023 | Sale | 561 | 226.62 | 127,134 | D |
03 Feb 2023 17:45 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 02 Feb 2023 | Sale | 963 | 225.8 | 217,445 | D |
03 Feb 2023 17:45 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 02 Feb 2023 | Sale | 73 | 223.97 | 16,350 | D |
28 Apr 2023 17:55 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 27 Apr 2023 | Sale | 103 | 197.08 | 20,299 | D |
28 Apr 2023 17:55 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 27 Apr 2023 | Sale | 64 | 195.65 | 12,522 | D |
28 Apr 2023 17:55 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 27 Apr 2023 | Sale | 625 | 194.94 | 121,838 | D |
28 Apr 2023 17:55 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 27 Apr 2023 | Sale | 562 | 193.93 | 108,989 | D |
28 Apr 2023 17:55 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 27 Apr 2023 | Sale | 122 | 193.18 | 23,568 | D |
20 Feb 2024 16:08 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 16 Feb 2024 | Sale | 121 | 149.03 | 18,033 | D |
20 Feb 2024 16:08 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 16 Feb 2024 | Sale | 519 | 148.24 | 76,937 | D |
20 Feb 2024 16:08 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 16 Feb 2024 | Sale | 369 | 147.5 | 54,428 | D |
29 Feb 2024 16:18 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 28 Feb 2024 | Sale | 1 | 158.09 | 158 | D |
29 Feb 2024 16:18 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 28 Feb 2024 | Sale | 14 | 157.3 | 2,202 | D |
29 Feb 2024 16:18 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 28 Feb 2024 | Sale | 170 | 155.45 | 26,426 | D |
29 Feb 2024 16:18 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 28 Feb 2024 | Sale | 100 | 156.38 | 15,638 | D |
29 Feb 2024 16:18 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 28 Feb 2024 | Sale | 216 | 154.54 | 33,381 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)